Original Article

You have full text access to this OnlineOpen article

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?†

Meta-Analysis of Randomized Trials

  1. Emilio Bria MD1,‡,§,*,
  2. Federica Cuppone MD1,‡,
  3. Diana Giannarelli PhD2,
  4. Michele Milella MD1,
  5. Enzo Maria Ruggeri MD3,
  6. Isabella Sperduti PhD2,
  7. Paola Pinnarò MD1,
  8. Edmondo Terzoli MD1,
  9. Francesco Cognetti MD1,
  10. Paolo Carlini MD1

Article first published online: 29 MAY 2009

DOI: 10.1002/cncr.24392

Issue

Cancer

Cancer

Volume 115, Issue 15, pages 3446–3456, 1 August 2009

Additional Information

How to Cite

Bria, E., Cuppone, F., Giannarelli, D., Milella, M., Ruggeri, E. M., Sperduti, I., Pinnarò, P., Terzoli, E., Cognetti, F. and Carlini, P. (2009), Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?. Cancer, 115: 3446–3456. doi: 10.1002/cncr.24392

Author Information

  1. 1

    Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy

  2. 2

    Biostatistics, Regina Elena National Cancer Institute, Rome, Italy

  3. 3

    Medical Oncology, Hospital “Belcolle”, Viterbo, Italy

  1. ‡

    The first 2 authors contributed equally to this article.

  2. §

    Fax: (011) 390652666219

*Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy

  1. †

    Presented and awarded at the Presidential Symposium of the 31st European Society for Medical Oncology Congress, Istanbul, Turkey, September 29-October 3, 2006. Preliminary data presented at the 42nd American Society of Medical Oncology annual meeting, Atlanta, Georgia, June 2-6, 2006.

Publication History

  1. Issue published online: 20 JUL 2009
  2. Article first published online: 29 MAY 2009
  3. Manuscript Accepted: 6 JAN 2009
  4. Manuscript Revised: 5 JAN 2009
  5. Manuscript Received: 11 DEC 2008

Funded by

  • National Ministry of Health and the Italian Association for Cancer Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (361K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicolas Mottet, Michel Peneau, Jean-Jacques Mazeron, Vincent Molinie, Pierre Richaud, Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial, European Urology, 2012,

    CrossRef

  2. 2
    Tsutomu Nishiyama, Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer, The Journal of Steroid Biochemistry and Molecular Biology, 2012, 129, 3-5, 179

    CrossRef

  3. 3
    Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, Nicolas Mottet, Fritz H. Schröder, Cora N. Sternberg, Urs E. Studer, Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer, European Urology, 2012, 61, 1, 11

    CrossRef

  4. 4
    David Dearnaley, Isabel Syndikus, Georges Sumo, Margaret Bidmead, David Bloomfield, Catharine Clark, Annie Gao, Shama Hassan, Alan Horwich, Robert Huddart, Vincent Khoo, Peter Kirkbride, Helen Mayles, Philip Mayles, Olivia Naismith, Chris Parker, Helen Patterson, Martin Russell, Christopher Scrase, Chris South, John Staffurth, Emma Hall, Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial, The Lancet Oncology, 2012, 13, 1, 43

    CrossRef

  5. 5
    Susan Masson, Raj Persad, Amit Bahl, HDR Brachytherapy in the Management of High-Risk Prostate Cancer, Advances in Urology, 2012, 2012, 1

    CrossRef

  6. 6
    P-L Kellokumpu-Lehtinen, M Hjälm-Eriksson, C Thellenberg-Karlsson, L Åström, L Franzen, T Marttila, M Seke, M Taalikka, C Ginman, Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial, Prostate Cancer and Prostatic Diseases, 2012,

    CrossRef

  7. 7
    Hiroyuki Konaka, Shin Egawa, Shiro Saito, Atsunori Yorozu, Hiroyuki Takahashi, Keiko Miyakoda, Masanori Fukushima, Takushi Dokiya, Hidetoshi Yamanaka, Nelson N Stone, Mikio Namiki, Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial, BMC Cancer, 2012, 12, 1, 110

    CrossRef

  8. 8
    C. Ferrandis, J.A. March, J.M. Martínez, J. Hernández, N. Diez, V. Morillo, F. García, P. Chuan, Combined external radiotherapy and hormone therapy in patients with locally advanced prostate cancer: Predictive factors of genitourinary toxicity, Actas Urológicas Españolas (English Edition), 2011, 35, 3, 146

    CrossRef

  9. 9
    Jonathan D. Grant, Mark S. Litwin, Lorna Kwan, Steve P. Lee, Michael L. Steinberg, Christopher R. King, Does Hormone Therapy Exacerbate the Adverse Effects of Radiotherapy in Men With Prostate Cancer? A Quality of Life Study, The Journal of Urology, 2011, 185, 5, 1674

    CrossRef

  10. 10
    Santiago Vilar González, Xavier Maldonado Pijuan, Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate, BJU International, 2011, 107, 8
    Direct Link:
  11. 11
    Hyeli Park, Sei Kyung Chang, Jayoung Kim, Bo Mi Lee, Seong Young Ko, Sung Joon Kim, Hyun Soo Shin, Permanent Brachytherapy of Localized Prostate Cancer: Preliminary Results, The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2011, 29, 2, 71

    CrossRef

  12. 12
    Peter Iversen, David G. McLeod, William A. See, Thomas Morris, Jon Armstrong, Manfred P. Wirth, Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years, BJU International, 2010, 105, 8
    Direct Link:
  13. You have free access to this content13
    AJ Hayden, JM Martin, AB Kneebone, M Lehman, KL Wiltshire, M Skala, D Christie, P Vial, R McDowall, K-H Tai, Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma, Journal of Medical Imaging and Radiation Oncology, 2010, 54, 6
    Direct Link:
  14. 14
    S. Vilar-González, X. Maldonado-Pijuan, I. Andrés-García, Does the pharmacological class effect between the different luteinizing hormone releasing hormone analogues used in the treatment of prostate cancer have to be assumed?, Actas Urológicas Españolas (English Edition), 2010, 34, 9, 749

    CrossRef

  15. 15
    S.J. Drouin, M. Rouprêt, A. Bossi, M. Bolla, Hormonothérapie combinée à la radiothérapie externe dans le cancer de prostate localement avancé : les effets secondaires contrecarrent-ils les bénéfices ?, Progrès en Urologie, 2010, 20, S186

    CrossRef

  16. 16
    N. Suzuki, M. Shimbo, Y. Amiya, S. Tomioka, T. Shima, S. Murakami, H. Nakatsu, S. Oota, J. Shimazaki, Outcome of Patients with Localized Prostate Cancer Treated by Radiotherapy After Confirming the Absence of Lymph Node Invasion, Japanese Journal of Clinical Oncology, 2010, 40, 7, 652

    CrossRef

  17. 17
    F. Bray, J. Lortet-Tieulent, J. Ferlay, D. Forman, A. Auvinen, Prostate cancer incidence and mortality trends in 37 European countries: An overview, European Journal of Cancer, 2010, 46, 17, 3040

    CrossRef

View Full Article (HTML) Get PDF (361K)